Metabolic / GLP-1

A thorough metabolic health assessment covering blood glucose, HbA1c, cholesterol, liver and kidney function, uric acid, and insulin resistance markers — with GP-led interpretation, lifestyle guidance, and medication support where appropriate.

Clinically supervised GLP-1 receptor agonist and dual incretin therapy for weight management and metabolic health. Dr Linsey Gani prescribes semaglutide and tirzepatide with evidence-based dose titration and specialist monitoring.

ATA Medical prescribes GLP-1 receptor agonists including semaglutide (Wegovy, Ozempic, Rybelsus) and tirzepatide to eligible adults for medically supervised weight management, with complimentary InBody body composition tracking at follow-up visits.

Endocrinologist-led GLP-1 receptor agonist pharmacotherapy for medically supervised obesity management. Weight loss medications are used as adjuvant therapy to lifestyle changes and are carefully monitored throughout treatment.

Doctor-supervised GLP-1 receptor agonist therapy using Wegovy (semaglutide) or Mounjaro (tirzepatide) with full dose titration, safety screening, side-effect management, and ongoing monitoring.

Clinically supervised GLP-1 receptor agonist therapy (semaglutide or liraglutide) for medically indicated weight loss, combined with nutrition support and regular physician monitoring.

Doctor-supervised GLP-1 weight loss programme combining semaglutide or liraglutide injection therapy with personalised nutrition guidance, exercise support, and regular medical monitoring for safe, sustained weight reduction.

Doctor-prescribed semaglutide (Ozempic, WeGovy) and oral Rybelsus programmes for metabolic health and sustainable weight loss, with clinical monitoring and dose titration managed by the Bay Aesthetics medical team throughout the treatment course.

Medically supervised GLP-1 receptor agonist weight management programme using FDA-approved medications. Includes physician assessment, dose titration, dietary guidance, and ongoing metabolic monitoring.

A medically supervised GLP-1 receptor agonist weight management programme combining semaglutide or liraglutide pharmacotherapy with registered dietitian support, metabolic monitoring, and personalised lifestyle coaching for sustainable, clinically meaningful weight loss.

A comprehensive metabolic health programme for type 1, type 2, or prediabetes combining continuous glucose monitoring, specialist doctor and dietitian consultations, HbA1c testing, and digital coaching via the NOVIFY app.

A medically supervised GLP-1 receptor agonist programme using semaglutide or liraglutide for men and women with excess weight or obesity. Includes metabolic baseline testing, personalised dosing with slow titration and ongoing monitoring and lifestyle support.

FeM Surgery's GLP-1 weight loss programme uses HSA-approved semaglutide (Wegovy) or tirzepatide (Mounjaro) under specialist medical supervision, delivering clinically proven 10–20% body weight reduction over 6–18 months with ongoing dose titration and lifestyle support.

A medically supervised GLP-1 receptor agonist weight management programme using semaglutide or liraglutide. Suitable for overweight or obese men and for those managing type 2 diabetes, with regular monitoring and lifestyle support included.

Doctor-led 3-month metabolic and weight management programme combining medical oversight, GLP-1 therapy where appropriate, dietitian guidance, and personalised exercise coaching for sustainable, evidence-based weight loss.

Dr Edwin Lim prescribes and supervises GLP-1 and GLP-1/GIP receptor agonist injections — semaglutide, tirzepatide, and liraglutide — for medically supervised weight management with transparent monthly pricing and regular clinical follow-up.

Physician-supervised semaglutide (GLP-1 receptor agonist) weight management programme with weekly subcutaneous injections, blood sugar monitoring, and regular clinical review for sustainable fat loss and metabolic improvement.

Medically prescribed GLP-1 receptor agonist injection pens including Liraglutide, Semaglutide, and Tirzepatide for clinically proven weight loss. Administered under doctor supervision with tailored dosing and regular follow-up monitoring.

Physician-supervised metabolic optimisation programme using GLP-1 receptor agonists (semaglutide, tirzepatide), continuous glucose monitoring, and precision nutrition protocols to address weight management, insulin resistance, and metabolic dysfunction.

Prescription GLP-1 receptor agonist therapy (injectables and oral medications) for medically-indicated weight loss and metabolic health improvement, supervised by senior consultant gastroenterologists with close monitoring for safety and efficacy.

Specialist-prescribed GLP-1 receptor agonist therapy and metabolic health optimisation for patients with obesity, type 2 diabetes, or insulin resistance, supervised by a consultant endocrinologist.

Physician-prescribed GLP-1 receptor agonist therapy for weight loss and metabolic optimisation, delivered as part of LIFT Clinic's evidence-based MetaboLIFT® protocol with ongoing medical monitoring.

Medically prescribed GLP-1 receptor agonist injections (including semaglutide) as part of Phoenix Medical Group's supervised weight management and metabolic health programme.